NEW YORK (GenomeWeb News) - Compugen said this week that Anat Cohen-Dayag and Martin Gerstel will serve as co-CEOs of the company. Cohen-Dayag started with the company in 2002, and she has served as VP for diagnostic biomarkers and drug targets. Before starting at Compugen, she was head of R&D at Mindsense Biosystems.
Gerstel began at Compugen in 1997 as chairman and was appointed president and CEO earlier this year. Before joining Compugen, Gerstel was co-chairman and CEO of ALZA Corporation and a director of the Pharmaceutical Research and Manufacturers of America.
Rules-Based Medicine has hired Tony Barnes to take the post of VP of clinical diagnostics, where he will lead strategic marketing as the company commercializes biomarker-based tests. Barnes previously was co-founder, CEO, and vice chairman of Oncimmune.
Susan Desmond-Hellmann will not stand for re-election to Affymetrix's board of directors at the company's annual stockholders meeting this June. According to a filing with the US Securities and Exchange Commission, Desmond-Hellman wants to focus more time on her new job as chancellor of the University of California, San Francisco.
Eric Topol, who is chief academic officer of Scripps Health and director of Scripps Translational Science Institute, has been named the inaugural chair of the Gary and Mary West Chair of Innovative Medicine at Scripps Health. The position was created through a $5 million endowment from the foundation. Topol also has been appointed to the board of directors of the West Wireless Health Institute.
"Through the development of wireless technologies, there is an extraordinary opportunity to change the future of medicine in an unprecedented way," Topol said in a statement. "As medicine focuses on digital technology and the use of wireless sensors to elegantly track individual patient data, the opportunities for better prevention and treatment are limitless."
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People in the News, a weekly roundup of industry comings and goings.